About Careers MedBlog Contact us

Side effect(s) of Obinutuzumab

Read the side effects of Obinutuzumab as described in the medical literature. In case of any doubt consult your doctor or pharmacist.

Gastrointestinal: Diarrhea, constipation, indigestion, loss of appetite

Nervous system: Dizziness, confusion, difficulty in speech or to walk, loss of balance

Respiratory: Cough, nasal congestion, sneezing, inflammation of the sinuses, nasopharyngitis

Musculoskeletal: Joint pain, pain in the extremities, muscle pain or cramps

Blood: Low levels of neutrophils, lymphocytes, white blood cells

Lab abnormalities: Decreased levels of calcium, potassium, sodium, and phosphate in the blood, increased liver enzymes, and creatinine levels

Others: Headache, itching, fever, weakness, vision problems

Other Precautions : Breastfeeding mothers should be advised not to breastfeed their babies during and 18 months after the obinutuzumab treatment is stopped.

Women of reproductive potential living with active male partners should follow an effective contraceptive measure during obinutuzumab treatment and must continue the contraception for at least 18 months after the last dose of obinutuzumab.

Inspect the obinutuzumab vials and the diluted solution for the presence of any visible solid matter or discoloration before administering it to the patient.

Drug Name : Obinutuzumab

Obinutuzumab is prescribed to treat chronic lymphocytic leukemia (CLL) in combination with chlorambucil and to treat follicular lymphoma (FL) either alone or in combination with bendamustine in adult patients whose cancer has not responded to previous chemotherapy.
More Info about Obinutuzumab


Recommended Reading
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close